BT8009, Zelenectide Pevedotin
BT8009, Duravelo-3
Phase 2 small_molecule active
Quick answer
BT8009, Zelenectide Pevedotin for NECTIN4 Amplified Advanced Breast Cancer is a Phase 2 program (small_molecule) at BICYCLE THERAPEUTICS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BICYCLE THERAPEUTICS
- Indication
- NECTIN4 Amplified Advanced Breast Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active